Aspira Women’s Health ( (AWHL) ) has released a notification of late filing.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Aspira Women’s Health Inc. has announced a delay in filing its Form 10-Q (Quarter Report) for the financial period ending March 31, 2025. The delay is primarily due to the need for additional time to complete accounting and disclosures related to recent debt and equity transactions. The company anticipates filing the report within a 5-day extension period. Financially, Aspira expects a significant change in its results, including a decrease in net loss and loss per share, attributed to a $1,500,000 milestone payment and reduced operating expenses. The company remains committed to compliance, with the notification signed by CEO Michael Buhle.
The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.
Spark’s Take on AWHL Stock
According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.
Aspira Women’s Health faces significant challenges with a weak financial position marked by negative equity and persistent cash flow issues. The technical indicators suggest bearish momentum, and the negative P/E ratio highlights valuation concerns. Overall, these factors contribute to a low stock score, reflecting the company’s risky financial state and uncertain market position.
To see Spark’s full report on AWHL stock, click here.
More about Aspira Women’s Health
Average Trading Volume: 4,762,421
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.28M
For an in-depth examination of AWHL stock, go to TipRanks’ Stock Analysis page.